Navigation Links
Helena Laboratories to Manage BIS and OFAC Screening via ATTUS WatchDOG® Pro

CHARLOTTE, N.C., Jan. 5, 2011 /PRNewswire/ -- ATTUS Technologies, Inc, adds Helena Laboratories, a clinical laboratory instrument and reagent manufacturer, to the growing list of global companies choosing the market leading WatchDOG® Pro for their BIS, OFAC and other watch list screening compliance.


Helena Laboratories is a leader in the development and distribution of new diagnostic tests, such as HemoHeel, which improve the health of millions of people around the world.  Through its global distributors, Helena delivers its products and services to over seventy countries in Europe, Central and South America, Australia and the Middle and Far East.  

"As the manufacturer of products that have the potential to positively impact so many people in both industrialized and third world countries, it's imperative that Helena's distribution not get slowed down by an inefficient watch list screening process," said Tom Fedell, president and CEO of ATTUS Technologies, Inc.  "With WatchDOG® Pro, they have a time efficient and cost effective solution to one of the most pressing obligations facing today's global manufacturers, their BIS and OFAC compliance."WatchDOG® Pro's advanced search algorithm allows precision watch list screening.  Businesses can cross check their entire customer database or individual customer transactions against a variety of relevant watch lists in order to meet their specific, regulatory compliance needs.  

"We are very impressed with WatchDOG® Pro's batch screening capabilities," said Justin Padia, Export Compliance Manager of Helena Laboratories.  "After implementation, we were able to double check our order history to ensure there were no previously missed watch list matches within our existing customer database.  And going forward, we can screen new customers on an ad hoc basis as well as do routine rechecks on our full database."

In addition to offering a wide range of regulatory compliance products and services, ATTUS provides clients with complimentary access to its highly trained and qualified customer service representatives.  "We pride ourselves on delivering the most advanced technology and risk consulting services but with a human touch," Fedell points out.  

"At Helena, we are using WatchDOG® Pro to screen all of our customers and ATTUS' customer support team has been very helpful and informative with all of our inquiries," Padia said, agreeing with Fedell.  "Their dedicated support was a key selling point for us; that, and the cost savings the product provides us because there is no per user charge."

The Bureau of Industry and Security (BIS), the agency responsible for U.S. export control policy, and the Office of Foreign Assets Control (OFAC), the U.S. Treasury department responsible for U.S. sanctions programs, both have strict compliance requirements for manufacturers exporting goods from the United States.  Businesses in violation of those requirements risk civil penalties and possible criminal charges.

About Helena LaboratoriesHelena Laboratories is a clinical laboratory instrument and reagent manufacturer.  Our clients include major medical centers, small hospitals, large reference laboratories and small private doctor's laboratories.  Corporate headquarters, located in Beaumont, Texas, a major port city 80 miles east of Houston, is comprised of over a quarter million square feet of research, manufacturing, inventory engineering and administrative facilities.  Our quality products and services are available worldwide.  Distribution is organized through companies specialized in the marketing and servicing of Helena products.  For more information, visit

About ATTUS Technologies, Inc.ATTUS Technologies, Inc. is an industry leader in software and services for regulatory compliance, homeland security and fraud prevention.   Over 4,500 financial institutions and other clients nationwide use ATTUS' solutions for compliance with the requirements of the Gramm-Leach-Bliley Act (GLBA), the USA PATRIOT Act, the Office of Foreign Assets Control (OFAC), the Financial Crimes Enforcement Network (FinCEN), anti-money laundering regulations, the Bank Secrecy Act (BSA), Regulation CC and Regulation E.  ATTUS, a wholly owned subsidiary of Computer Services, Inc., is based in Charlotte, North Carolina.  For more information about ATTUS, visit

About Computer Services, Inc. Computer Services, Inc. (CSI) delivers core banking, payments processing, Internet, card services, risk assessment, fraud prevention, network management, regulatory compliance and document delivery solutions to financial institutions and corporate entities across the nation.  Technology planning, personal account management and world class customer service explain why CSI is known as one of the nation's premier providers of technology solutions for the financial services industry. CSI's stock is traded on the OTCQX under the symbol CSVI.  For more information about CSI, visit more information, contact:

Jalana Ballen,  Marketing Director  888.494.8449 or

SOURCE ATTUS Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
3. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
4. Romark Laboratories Raises $18 Million in Institutional Financing
5. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
6. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
7. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
8. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
9. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
10. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
11. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):